GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,000 | -6.2% | 316 | -16.4% | 0.01% | 0.0% |
| Q1 2019 | $16,000 | -73.3% | 378 | -72.5% | 0.01% | -66.7% |
| Q2 2016 | $60,000 | +7.1% | 1,375 | 0.0% | 0.02% | +12.5% |
| Q1 2016 | $56,000 | +1.8% | 1,375 | 0.0% | 0.02% | +6.7% |
| Q4 2015 | $55,000 | +3.8% | 1,375 | 0.0% | 0.02% | +15.4% |
| Q3 2015 | $53,000 | -7.0% | 1,375 | 0.0% | 0.01% | +30.0% |
| Q2 2015 | $57,000 | -19.7% | 1,375 | -10.1% | 0.01% | -23.1% |
| Q1 2015 | $71,000 | +9.2% | 1,530 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $65,000 | -7.1% | 1,530 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $70,000 | -99.6% | 1,530 | -99.5% | 0.01% | -99.6% |
| Q2 2014 | $17,999,000 | +0.8% | 336,560 | +0.7% | 3.01% | -7.6% |
| Q1 2014 | $17,850,000 | -28.2% | 334,075 | -28.2% | 3.26% | -32.1% |
| Q4 2013 | $24,846,000 | -3.0% | 465,360 | -8.8% | 4.80% | +4.4% |
| Q3 2013 | $25,603,000 | +25.0% | 510,325 | +24.5% | 4.60% | +15.1% |
| Q2 2013 | $20,489,000 | – | 410,020 | – | 3.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |